Telix Pharmaceuticals Provides Regulatory Update On TLX250-CDX
Aug 28 (Reuters) - Telix Pharmaceuticals Ltd TLX.AX:
PROVIDES REGULATORY UPDATE ON TLX250-CDX
RECEIVES FDA COMPLETE RESPONSE LETTER FOR TLX250-CDX
FDA REQUESTS ADDITIONAL DATA FOR TLX250-CDX MANUFACTURING
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.